Skip to main content
OpenTrials

Clinical trial condition

Thrombotic Microangiopathies

Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.

30 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Thrombotic Microangiopathies trial results

Recruiting

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

NCT06727669

Conditions
Arterial Thromboembolism, Autoimmune Diseases, Bleeding Disorder, +45 more
Locations
  • Peking University Insititute of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China
  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Department of Hematology, Beijing Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

Italian iTTP Registry

NCT06376786

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, MI, Italy
View Trial Details
Completed

A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT).

NCT07732361

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +5 more
Locations
  • Research Facility Boston, Massachusetts, United States
  • Research Facility Akron, Ohio, United States
  • Research Facility Salt Lake City, Utah, United States
  • Research Facility Brussels, Brussels Capital, Belgium
View all 43 locations
View Trial Details
Completed

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

NCT04543591

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +4 more
Locations
  • Research Site Tampa, Florida, United States
  • Research Site Grosse Pointe Farms, Michigan, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View all 66 locations
View Trial Details
Completed

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT04889430

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ of California at Los Angeles Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Univ of California at Sacramento Sacramento, California, United States
View all 36 locations
View Trial Details

Related conditions